Jens Vollmar

1.6k total citations
18 papers, 1.1k citations indexed

About

Jens Vollmar is a scholar working on Epidemiology, Hepatology and Virology. According to data from OpenAlex, Jens Vollmar has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Hepatology and 7 papers in Virology. Recurrent topics in Jens Vollmar's work include Hepatitis Viruses Studies and Epidemiology (7 papers), Hepatitis B Virus Studies (7 papers) and Poxvirus research and outbreaks (7 papers). Jens Vollmar is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (7 papers), Hepatitis B Virus Studies (7 papers) and Poxvirus research and outbreaks (7 papers). Jens Vollmar collaborates with scholars based in Germany, United Kingdom and United States. Jens Vollmar's co-authors include Paul Chaplin, Alfred von Krempelhuber, Amanda Handley, Thomas Höhler, Peter M. Schneider, Rolf Fimmers, Esther Reuss, Christian Rittner, Christine M. Freitag and R. Neuhaus and has published in prestigious journals such as The Lancet, PLoS ONE and Hepatology.

In The Last Decade

Jens Vollmar

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jens Vollmar Germany 16 643 469 323 287 280 18 1.1k
Nina F. Rose United States 12 642 1.0× 434 0.9× 151 0.5× 184 0.6× 300 1.1× 19 1.1k
Janie Parrino United States 17 787 1.2× 320 0.7× 162 0.5× 42 0.1× 403 1.4× 27 1.4k
R. Berger Switzerland 20 748 1.2× 131 0.3× 88 0.3× 140 0.5× 161 0.6× 44 1.1k
Pilar Pérez‐Romero Spain 22 782 1.2× 136 0.3× 126 0.4× 83 0.3× 197 0.7× 73 1.2k
Robert C. Colgrove United States 15 746 1.2× 237 0.5× 224 0.7× 107 0.4× 146 0.5× 30 1.1k
Tomas Doyle United Kingdom 11 291 0.5× 641 1.4× 244 0.8× 79 0.3× 525 1.9× 14 1.1k
Justin Pollara United States 20 466 0.7× 738 1.6× 268 0.8× 43 0.1× 773 2.8× 58 1.5k
Isabella Abbate Italy 22 449 0.7× 694 1.5× 260 0.8× 260 0.9× 363 1.3× 87 1.4k
Himal Lal Belgium 14 1.3k 2.0× 265 0.6× 83 0.3× 56 0.2× 189 0.7× 23 1.6k
S. Debrus Belgium 18 650 1.0× 188 0.4× 61 0.2× 126 0.4× 141 0.5× 31 962

Countries citing papers authored by Jens Vollmar

Since Specialization
Citations

This map shows the geographic impact of Jens Vollmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Vollmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Vollmar more than expected).

Fields of papers citing papers by Jens Vollmar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Vollmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Vollmar. The network helps show where Jens Vollmar may publish in the future.

Co-authorship network of co-authors of Jens Vollmar

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Vollmar. A scholar is included among the top collaborators of Jens Vollmar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Vollmar. Jens Vollmar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Holl, Katsiaryna, Mats Rosenlund, Carlo Giaquinto, et al.. (2015). The Impact of Childhood Acute Otitis Media on Parental Quality of Life in a Prospective Observational Cohort Study. Clinical Drug Investigation. 35(10). 613–624. 19 indexed citations
2.
Sonnenburg, Frank von, Stephan de la Motte, Alfred von Krempelhuber, et al.. (2015). Cardiac Safety of Modified Vaccinia Ankara for Vaccination against Smallpox in a Young, Healthy Study Population. PLoS ONE. 10(4). e0122653–e0122653. 34 indexed citations
3.
Sonnenburg, Frank von, Ulf Darsow, Johannes Ring, et al.. (2014). Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis. Vaccine. 32(43). 5696–5702. 41 indexed citations
4.
Greenberg, Richard N., Edgar T. Overton, David W. Haas, et al.. (2012). Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects. The Journal of Infectious Diseases. 207(5). 749–758. 86 indexed citations
5.
Liese, Johannes G., Carlo Giaquinto, Sven‐Arne Silfverdal, et al.. (2011). PSS37 the Clinical and Economic Burden of Acute Otitis Media: A Large Prospective Observational Cohort Study in Europe. Value in Health. 14(7). A508–A509. 1 indexed citations
6.
Krempelhuber, Alfred von, Jens Vollmar, Rolf Pokorny, et al.. (2009). A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®. Vaccine. 28(5). 1209–1216. 91 indexed citations
7.
Frey, Sharon E., Frances K. Newman, Jeffrey S. Kennedy, et al.. (2007). Clinical and immunologic responses to multiple doses of IMVAMUNE® (Modified Vaccinia Ankara) followed by Dryvax® challenge. Vaccine. 25(51). 8562–8573. 92 indexed citations
8.
Nothdurft, H. D., et al.. (2006). Combined Vaccination against Hepatitis A, Hepatitis B, and Typhoid Fever: Safety, Reactogenicity, and Immunogenicity. Journal of Travel Medicine. 9(3). 122–126. 4 indexed citations
9.
Reiter, A., et al.. (2006). Changes of basic bone turnover parameters in short-term and long-term patients with spinal cord injury. European Spine Journal. 16(6). 771–776. 58 indexed citations
10.
Harrer, Ellen G., Michael Bäuerle, Barbara Ferstl, et al.. (2005). Therapeutic Vaccination of HIV-1-Infected Patients on Haart with a Recombinant HIV-1 Nef-Expressing Mva: Safety, Immunogenicity and Influence on Viral Load during Treatment Interruption. Antiviral Therapy. 10(2). 285–300. 86 indexed citations
11.
Vollmar, Jens, T. Thomsen, Luis Mateo, et al.. (2005). Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine. Vaccine. 24(12). 2065–2070. 127 indexed citations
12.
Bienzle, Ulrich, Matthias Günther, R. Neuhaus, et al.. (2003). Immunization With An Adjuvant Hepatitis B Vaccine After Liver Transplantation for Hepatitis B–Related Disease. Hepatology. 38(4). 811–819. 108 indexed citations
13.
Banz, Kurt, Stefan Wagenpfeil, A. Neiß, et al.. (2003). The cost-effectiveness of routine childhood varicella vaccination in Germany. Vaccine. 21(11-12). 1256–1267. 75 indexed citations
14.
Nothdurft, Hans Dieter, Jane N. Zuckerman, Jürgen Knobloch, et al.. (2002). A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine. 20(7-8). 1157–1162. 55 indexed citations
15.
Höhler, Thomas, Esther Reuss, Christian Rittner, et al.. (2002). Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. The Lancet. 360(9338). 991–995. 161 indexed citations
16.
Manns, Michael P., P. Neuhaus, Gillian Atkinson, et al.. (2001). Famciclovir treatment of hepatitis B infection following liver transplantation: a long‐term, multi‐centre study. Transplant Infectious Disease. 3(1). 16–23. 18 indexed citations
17.
Kallinowski, B., Antje Knöll, Roland Sänger, et al.. (2000). Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?. Vaccine. 19(1). 16–22. 26 indexed citations
18.
Wedemeyer, Heiner, Klaus Pethig, D. Petzold, et al.. (1999). FAMCICLOVIR TREATMENT OF CHRONIC HEPATITIS B IN HEART TRANSPLANT RECIPIENTS: A PROSPECTIVE TRIAL1,2. Transplantation. 68(10). 1503–1511. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina F. Rose Breakdown of academic impact, for papers by Janie Parrino Breakdown of academic impact, for papers by R. Berger Breakdown of academic impact, for papers by Pilar Pérez‐Romero Breakdown of academic impact, for papers by Robert C. Colgrove Breakdown of academic impact, for papers by Tomas Doyle Breakdown of academic impact, for papers by Justin Pollara Breakdown of academic impact, for papers by Isabella Abbate Breakdown of academic impact, for papers by Himal Lal Breakdown of academic impact, for papers by S. Debrus
Rankless by CCL
2026